• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Repurposing Pirlindole for Multiple Sclerosis

August 24, 2018Featured, Multiple Sclerosis, Nervous System Disorders, Vizit Graphs
Repurposing Pirlindole for Multiple SclerosisChristos Andronis2020-08-03T13:42:45+00:00
Repurposing Pirlindole for Multiple Sclerosis

Mechanism of action of Pirlindole in Multiple Sclerosis.

Explore the live graph.

Literature analysis for systematic drug repurposing: a case study from Biovista. Lekka, E., S.N. Deftereos, A. Persidis, A. Persidis, and C. Andronis. 2011. Drug Discovery Today: Therapeutic Strategies. 8:103–108.
View article on ScienceDirect

Tags: COGNITION, MONOAMINE OXIDASE A, MULTIPLE SCLEROSIS, MYELINATION, NEUROGENESIS, PIRLINDOLE, SUPEROXIDE DISMUTASE

Post navigation

← Biomarkers for ALS
Dinoprostone for inflammatory diseases →

Vizit Graphs Tag Cloud

ALBUMIN COGNITION AUTOPHAGY LACTATE DEHYDROGENASE INFLAMMATORY RESPONSE PSEUDOMONAS AERUGINOSA INTERFERON IL10 COVID-19 RAS TMPRSS2 ALZHEIMER'S DISEASE PARKINSON DISEASE TNF IL2 LISTERIA MONOCYTOGENES IL1B PD-1 MYALGIA STAPHYLOCOCCUS AUREUS CASP3 HELICOBACTER PYLORI APOPTOTIC PROCESS NFKB1 CELL PROLIFERATION RHEUMATOID ARTHRITIS INSULIN INFLAMMATION IL6 COAGULATION IFNG CD4 CELL DIFFERENTIATION ACE ANGIOTENSIN II IMMUNE RESPONSE CANDIDA ALBICANS IMMUNITY NEUTROPHILS SARS-COV-2 ESCHERICHIA COLI METFORMIN AGING ACE2 CANCER

© 2021 Biovista Vizit All Rights Reserved.